一种治疗前列腺癌的中药制剂、制备方法和用途
By adding traditional Chinese medicines such as Cremastra appendiculata, Hedyotis diffusa, Scutellaria barbata, Canavalia gladiata, and toad skin to Yishen Tonglong Decoction, a new traditional Chinese medicine preparation was formed, which solved the problem of poor efficacy in the existing treatment of prostate cancer and achieved better tumor cell inhibition and apoptosis promotion effects.
Patent Information
- Authority / Receiving Office
- CN · China
- Patent Type
- Patents(China)
- Current Assignee / Owner
- THE FIRST HOSPITAL OF HUNAN UNIV OF CHINESE MEDICINE (CLINICAL RES INST OF TRADITIONAL CHINESE MEDICINE)
- Filing Date
- 2024-07-30
- Publication Date
- 2026-07-17
AI Technical Summary
Existing traditional Chinese medicine preparations have limited effectiveness in treating prostate cancer, and there is a need to further improve their ability to inhibit tumor cell proliferation and promote cell apoptosis.
The formula incorporates Chinese medicinal ingredients such as Cremastra appendiculata, Hedyotis diffusa, Scutellaria barbata, Canavalia gladiata, and toad skin to form a new combination of Chinese medicinal herbs. These herbs are then decocted to obtain a Chinese medicine preparation for the treatment of prostate cancer.
Compared to the original Yishen Tonglong Decoction, the new Chinese medicine preparation is more effective in inhibiting tumor cell proliferation, promoting cell apoptosis, and significantly improving the treatment effect of prostate cancer.
Smart Images
Figure CN118845969B_ABST